Lipocine Inc. 4
4 · Lipocine Inc. · Filed Jun 17, 2016
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Fink Jeffrey Arvin
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-06-14$8.02/sh+10,000$80,200→ 10,000 totalExercise: $8.02From: 2017-06-14Exp: 2026-06-13→ Common stock (10,000 underlying)
Footnotes (1)
- [F1]100% vesting one year from date of grant